4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-321152
Options or other derivatives
- Director acquired 8,592 shares (grant or award)
- Director returned 8,592 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
LAPORTE KATHLEEN · Director
Table II: Derivative
14 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form Director Stock Option (Right to Buy) | +1,392 | 1,392 | D |
| 2025-12-12 | Returned to the company : show line 2 in the form Director Stock Option (Right to Buy) | −1,392 | 0 | D |
| 2025-12-12 | Grant or award : show line 3 in the form Director Stock Option (Right to Buy) | +1,250 | 1,250 | D |
| 2025-12-12 | Returned to the company : show line 4 in the form Director Stock Option (Right to Buy) | −1,250 | 0 | D |
| 2025-12-12 | Grant or award : show line 5 in the form Director Stock Option (Right to Buy) | +1,250 | 1,250 | D |
| 2025-12-12 | Returned to the company : show line 6 in the form Director Stock Option (Right to Buy) | −1,250 | 0 | D |
| 2025-12-12 | Grant or award : show line 7 in the form Director Stock Option (Right to Buy) | +1,250 | 1,250 | D |
| 2025-12-12 | Returned to the company : show line 8 in the form Director Stock Option (Right to Buy) | −1,250 | 0 | D |
Loading xslF345X05/ownership.xml…